Global Protein Therapeutics Drugs Market Growth 2024-2030
The global Protein Therapeutics Drugs market is projected to grow from US$ 308160 million in 2024 to US$ 477510 million in 2030, at a CAGR of 7.6%.
Key features
- Growth driven by chronic disease prevalence and plasma-derived therapies.
- Increase in cancer cases expected to drive market demand.
Segmentation by Type
- Monoclonal Antibodies
- Insulin
- Fusion Protein
- Erythropoietin
- Interferon
- Human Growth Hormone
- Others
Segmentation by Application
- Cancer
- Metabolic Disorders
- Immunologic Disorders
- Hematological Disorders
- Hormonal Disorders
- Genetic Disorders
- Others
Market by Region
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
Company Coverage
- Johnson and Johnson
- Pfizer Inc
- F. Hoffmann La Roche Ltd
- Novo Nordisk AS
- Sanofi
- Amgen Inc
- Merck and Co., Inc
- Abbott Laboratories
- Baxter International Inc
- Eli Lilly And Company
- AbbVie
- Novartis
- Gilead Sciences
- Bristol-Myers Squibb
- Innovent
- AstraZeneca
- Hengrui Medicine
- Takeda
- Kanghong Pharma
- Seagen
- Sobi
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Protein Therapeutics Drugs market?
- What factors are driving Protein Therapeutics Drugs market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Protein Therapeutics Drugs market opportunities vary by end market size?
- How does Protein Therapeutics Drugs break out by Type, by Application?
Frequently Asked Questions
Protein Therapeutics Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Protein Therapeutics Drugs report is categorised based on following features:
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market
Protein Therapeutics Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.